{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:06Z","timestamp":1750538406930,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We present different findings on <jats:sup>18<\/jats:sup>F-fluciclovine (Axumin) PET\/CT and <jats:sup>18<\/jats:sup>F-NaF PET\/CT images in a patient with prostate cancer metastasis. <jats:sup>18<\/jats:sup>F-Fluciclovine PET\/CT scan showed intense uptake in left adrenal gland metastasis, only faint to mild uptake in multiple sclerotic osseous metastasis where <jats:sup>18<\/jats:sup>F-NaF bone PET\/CT demonstrated intense uptake at these sites. Both examinations are needed to accurately evaluate visceral and osseous metastasis from prostate cancer.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004583","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T23:20:06Z","timestamp":1675120806000},"page":"330-331","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Complementary Role of 18F-Fluciclovine PET\/CT and 18F-NaF PET\/CT in Detecting Prostate Cancer Metastasis"],"prefix":"10.1097","volume":"48","author":[{"given":"Feng","family":"Xu","sequence":"first","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Liu","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[{"name":"Pathology, Washington DC VA Medical Center, Washington, DC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2967\/jnumed.110.077933","article-title":"Molecular mechanisms of bone 18F-NaF deposition","volume":"51","year":"2010","journal-title":"J Nucl Med"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.345130061","article-title":"Newer PET application with an old tracer: role of 18F-NaF skeletal PET\/CT in oncologic practice","volume":"34","year":"2014","journal-title":"Radiographics"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1148\/rg.2017170035","article-title":"Clinical PET imaging in prostate cancer","volume":"37","year":"2017","journal-title":"Radiographics"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2967\/jnumed.117.204032","article-title":"Update on 18F-Fluciclovine PET for prostate cancer imaging","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jjco\/hyz072","article-title":"Diagnostic performance of 18F-fluciclovine PET\/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial","volume":"49","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MNM.0000000000001352","article-title":"Diagnostic accuracy of 18F-fluciclovine PET\/CT in primary lymph node staging of prostate cancer","volume":"42","year":"2021","journal-title":"Ncul Med Commun"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jbo.2015.08.002","article-title":"The role of 18F-NaF PET\/CT in metastatic bone disease","volume":"4","year":"2015","journal-title":"J Bone Oncol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.semnuclmed.2016.07.003","article-title":"18F-NaF-PET\/CT and 99mTc-MDP bone scintigraphy in the detection of bone metastasis in prostate cancer","volume":"46","year":"2016","journal-title":"Semin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:05:28Z","timestamp":1750536328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004583","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}